Condition 1: Major depressive disorder (moderate ). Condition 2: Major depressive disorder (severe). Major depressive disorder, single episode, moderate Major depressive disorder, single episode, severe without psychotic features
Conditions
Interventions
Intervention 1: Control group: They will receive oral fluoxetine, as a standard treatment, at a dose of 20-60 mg, for 2 months. Intervention 2: Intervention group 1: They will receive 8 sessions of mi
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
10 Years to No maximum
Inclusion criteria
Inclusion criteria: Moderate or severe underlying depression, based on psychiatrist's diagnosis Education level of at least elementary school Age over 10 years old
Exclusion criteria
Exclusion criteria: Having organic brain disorders and mental retardation Having other underlying psychiatric disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression status. Timepoint: Before the intervention, two months after starting treatment. Method of measurement: The Beck questionnaire.;Quality of life status. Timepoint: Before the intervention, two months after starting treatment. Method of measurement: SF-36 quality of life questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Kamal Solati
Shahre-kord University of Medical Sciences
Outcome results
None listed